Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
156.40    2.40 (1.56%)
Bid:
156.40
Ask:
156.60
Spread: 0.20 (0.128%)
Market Cap: £893.79m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Trading update

14 Jan 2021 07:00

RNS Number : 6200L
Elementis PLC
14 January 2021
 

Elementis plc

Trading Update

Sequential revenue improvement, FY 20 adjusted operating profit $81-83m

Significant reduction in net debt, anticipated to be under $415m

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues a trading update for the three months ended 31 December 2020.

Fourth quarter business performance

 

Fourth quarter revenue is expected to be ahead of the third quarter driven by improved volumes and largely stable pricing. Overall performance in the quarter is anticipated to be in line with management expectations, helped by tight cost management and supply chain efficiencies. As a result, adjusted operating profit for 2020 is expected to be $81-83m.

· Coatings has continued to perform well in Q4, albeit at lower levels than the prior year period, and remains on track to deliver improved operating margins versus the prior year.

 

· Personal Care sales remain materially lower than the prior year period in both Cosmetics and AP Actives, due to the continuation of COVID-19 related social and travel restrictions that have reduced consumption. Q4 performance is anticipated to be in line with Q3 levels. 

 

· Talc volumes continued to recover, driven by improved long-life plastic demand for automotive applications and resilience in coatings. As a result, Q4 revenue is expected to be ahead of the prior year period.

· Chromium demand has sequentially improved, driven by increased demand for industrial applications such as leather tanning and metal plating. As a result, Q4 revenue is anticipated to be broadly in line with the prior year period.

 

· Energy continues to experience very weak market conditions with rig counts and activity levels remaining subdued.

 

In the fourth quarter we have continued to deliver against our Innovation, Growth and Efficiency strategy. For full year 2020 we launched 12 new products, captured over $30m of new business and delivered $15m of in year cost savings.

For 2021, whilst our new business and innovation pipelines are encouraging, we continue to face temporary demand challenges from COVID-19, particularly in Personal Care where we expect performance will recover when social and travel restrictions are lifted. As a result of the recently announced closure of our plant in Charleston, West Virginia, we have made further progress underpinning $10m of supply chain cost efficiencies, and our new AP Actives plant in India remains on track for mid-2021 start up.

Liquidity and balance sheet

 

As result of tight working capital management and disciplined capital expenditure, net debt* at the end of 2020 is anticipated to be under $415m, representing a significant reduction from $454m at the start of the year.

 

Elementis has a proven cash generative business model, with average operating cash conversion above 90% over the last 3 years, and the Group continues to operate with ample liquidity, with over $300m immediately available through committed lending facilities.

 

 

 

Enquiries

Elementis plc

James Curran, Investor Relations Tel: 020 7067 2994

 

Tulchan

Martin Robinson Tel: 020 7353 4200

David Allchurch

 

* Excluding IFRS 16 impact

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMMRFGGMZM
Date   Source Headline
8th Mar 20185:35 pmPRNDirector/PDMR Shareholding
7th Mar 201811:00 amPRNDirector/PDMR Shareholding
6th Mar 201811:04 amPRNDirector/PDMR Shareholding
6th Mar 201811:01 amPRNDirector/PDMR Shareholding
1st Mar 20183:00 pmPRNBlocklisting - Interim Review
28th Feb 20183:18 pmPRNHolding(s) in Company
28th Feb 20183:14 pmPRNTotal Voting Rights
28th Feb 201811:55 amRNSCompletion of sale of Surfactants business
27th Feb 20187:00 amRNSPreliminary Results
2nd Jan 20181:00 pmPRNTotal Voting Rights
12th Dec 20177:00 amRNSElementis announces sale of Surfactants business
8th Dec 20179:00 amPRNCompany Secretary Change
30th Nov 20171:00 pmPRNTotal Voting Rights
1st Nov 201712:30 pmPRNDirector Declaration
1st Nov 201711:00 amPRNHolding(s) in Company
31st Oct 201711:00 amPRNTotal Voting Rights
27th Oct 20177:00 amPRNTrading Statement
2nd Oct 20174:02 pmPRNTotal Voting Rights
11th Sep 20171:00 pmPRNDirector/PDMR Shareholding
6th Sep 20172:00 pmPRNDirector/PDMR Shareholding
5th Sep 20173:00 pmPRNDirector/PDMR Shareholding
5th Sep 20171:00 pmPRNDirector/PDMR Shareholding
1st Aug 20177:00 amRNSHalf-year Report
31st Jul 201712:00 pmPRNBlocklisting Return
31st Jul 201710:00 amPRNTotal Voting Rights
9th Jun 201711:00 amPRNDirector/PDMR Shareholding
7th Jun 201711:00 amPRNHolding(s) in Company
31st May 20172:00 pmPRNTotal Voting Rights
18th May 201711:00 amPRNAdditional Listing
15th May 201711:00 amPRNHolding(s) in Company
28th Apr 201711:00 amPRNTotal Voting Rights
26th Apr 201711:00 amPRNDirector/PDMR Shareholding
25th Apr 20174:00 pmPRNHolding(s) in Company
25th Apr 20173:00 pmPRNDirectorate Change
25th Apr 20172:00 pmPRNResult of AGM
25th Apr 20177:00 amPRNAGM Trading Statement
20th Apr 20174:00 pmPRNHolding(s) in Company
18th Apr 201711:00 amPRNHolding(s) in Company
7th Apr 20173:18 pmPRNDirector/PDMR Shareholding
5th Apr 201711:01 amPRNDirector/PDMR Shareholding
5th Apr 201711:00 amPRNDirector/PDMR Shareholding
5th Apr 201711:00 amPRNDirector/PDMR Shareholding
4th Apr 20174:00 pmPRNHolding(s) in Company
31st Mar 201711:00 amPRNTotal Voting Rights
24th Mar 20174:01 pmPRNElementis announces completion of acquisition
22nd Mar 20178:43 amPRNHolding(s) in Company
21st Mar 20171:00 pmPRNAnnual Financial Report
20th Mar 20171:02 pmPRNElementis announces sale of US colourants business
9th Mar 20179:00 amPRNDirector/PDMR Shareholding
9th Mar 20179:00 amPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.